Seligman Research

Seligman Research appears to have been a small research and activist short-selling operation rather than a drug developer, pharmaceutical company, or healthcare services provider. Public references primarily link the name to a December 18, 2019 report on Allakos, a biotech company, and there is little evidence of an operating biotech pipeline, therapeutic platform, or commercial healthcare business under this name. Based on available web evidence, Seligman Research was adjacent to the biotech sector through investigative or investment research on life sciences companies, not through developing medicines or healthcare products. There is also no clear evidence of current active operations, a corporate website, or a maintained business presence.